Legal termination of a pregnancy resulting from transplanted cryopreserved ovarian tissue due to cancer recurrence

  • Emil Hagen Ernst
  • Birgitte Vrou Offersen
  • Claus Yding Andersen
  • Erik Ernst
Fertility Preservation

Abstract

Purpose

To report on a woman who conceived naturally and had a normal intrauterine pregnancy following transplantation of frozen/thawed ovarian tissue but decided to have an early abortion due to recurrence of breast cancer.

Methods

The patient was diagnosed breast cancer and received antineoplastic treatment that forced her into premature ovarian insufficiency and infertility. Ovarian tissue cryopreserved prior to chemotherapy was transplanted following cancer treatment restoring fertility and regular menstrual cycles.

Results

The patient conceived 6 month after transplantation. However, she experienced recurrence of breast cancer and decided on legal termination of the pregnancy in the first trimester.

Discussion

The obtained pregnancy only 6 month following transplantation underlines the ability of the procedure. The recurrence occurred near the original site of the tumor and was most unlikely related to the transplantation. The activity of the transplanted tissue is likely to be destroyed by the renewed antineoplastic treatment she will receive. However, she still has the majority of one ovary cryostored and may later want to undergo additional transplantation to regain fertility or to have menstrual cycles back.

Keywords

Transplantation Fertility preservation Cancer Ovarian cryopreservation Premature ovarian insufficiency 

Notes

Acknowledgement

The financial support from the foundations of Civil Engineer Frode V. Nyegaard & wife, The Health Faculty at Aarhus University, the Danish Cancer Society (DP05112/ R2-A41-09-S2), The Danish Medical Research Council (271-07-0452; 09-072265), the Novo Nordic Foundation, Sophus Carl Emil Friis and wife Olga Doris Friis’ foundation, and the University Hospital of Copenhagen, is gratefully acknowledged.

Conflict of interest

None declared

References

  1. 1.
    Jemal A, Ward E, Thun M. Declining death rates reflect progress against cancer. PLoS One. 2010;5:e9584.PubMedCrossRefGoogle Scholar
  2. 2.
    Lamar CA, Decherney AH. Fertility preservation: state of the science and future research directions. Fertil Steril. 2009;91:316–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Zalel Y, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Eng J Med. 2005;21:318–21.CrossRefGoogle Scholar
  4. 4.
    Schmidt KT, Rosendahl M, Ernst E, et al. Autotransplantation of cryopreserved ovarian tissue in 12 women with chemotherapy-induced premature ovarian failure: the Danish experience. Fertil Steril. 2011;95:695–701.PubMedCrossRefGoogle Scholar
  5. 5.
    Detti L, Daniel CM, Williams LJ. Applicability of adult techniques for ovarian preservation to childhood cancer patients. J Assist Reprod Genet. 2012;29:985–95.PubMedCrossRefGoogle Scholar
  6. 6.
    Demeestere I, Simon P, Buxant F, Robin V, Fernandez SA, Centner J, et al. Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report. Hum Reprod. 2006;21:2010–4.PubMedCrossRefGoogle Scholar
  7. 7.
    Yding Andersen C, Kristensen SG, Greve T, Tryde Schmidt K. Cryopreservation of ovarian tissue for fertility preservation in young female oncological patients. Future Oncol. 2012;8:595–608.CrossRefGoogle Scholar
  8. 8.
    Andersen CY, Silber SJ, Berghold SH, Jorgensen JS, Ernst E. Long-term duration of function of ovarian tissue transplants: case reports. Reprod Biomed Online. 2012;25:128–32.PubMedCrossRefGoogle Scholar
  9. 9.
    Schmidt KT, Byskov AG, Nyeboe Andersen A, Müller J, Yding Andernsen C. Density and distribution of primordial follicles in single pieces of cortex from 21 patients and in individual pieces of cortex from three entire human ovaries. Hum Reprod. 2003;18:1158–64.PubMedCrossRefGoogle Scholar
  10. 10.
    Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Eng J Med. 2005;16:1659–72.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Emil Hagen Ernst
    • 1
  • Birgitte Vrou Offersen
    • 2
  • Claus Yding Andersen
    • 3
  • Erik Ernst
    • 4
  1. 1.Institute for Biomedicine – Section WestAarhus UniversityAarhus CDenmark
  2. 2.Department of OncologyAarhus University HospitalAarhusDenmark
  3. 3.Laboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children and Reproduction, Copenhagen University Hospital, Faculty of Health SciencesCopenhagen UniversityCopenhagenDenmark
  4. 4.Department of Gynaecology and ObstetricsAarhus University HospitalAarhusDenmark

Personalised recommendations